Director – Early Assets Medical Publications, Immuno-Oncology/Oncology

Bristol-Myers Squibb Lawrence Township, NJ

About the Job

Description:

About Bristol-Myers Squibb\:

 

Bristol-Myers Squibb is a global biopharmaceutical company whose mission is to discover, develop and deliver innovative medicines that help patients prevail over serious diseases.

 

One shared journey is moving us forward at Bristol-Myers Squibb. Around the world, we are passionate about making an impact on the lives of patients with serious disease. Empowered to apply our individual talents and ideas so that we can learn and grow together. And driven to make a difference, from innovative research to hands-on community support.  Bristol-Myers Squibb recognizes the importance of balance and flexibility in our work environment. We offer a wide variety of competitive benefits, services and programs that provide our employees the resources to pursue their goals, both at work and in their personal lives.

 

Responsibilities\:

  • Accountable for ensuring the clear, accurate and scientifically rigorous communication of BMS data that inform the medical community about our early Oncology pipeline.  This role will be report to the Lead, - Biomarkers, Next Generation, Pan Tumor Medical Publications & Scientific Content

  • Partner with Medical Leads working collaboratively across functions and markets to ensuring timely decisions on aspects impacting planning & execution of practice informing publications for defined assets

  • Work cooperatively across medical publication team leads across Oncology to ensure successful and seamless integration of publications supporting pipeline assets as they advance through development to commercialization

  • Engage and effectively align across a broad range of internal stakeholders (DT, GCR, ECTR, GBS, Global & key market teams, Med Info, Public Affairs, Health Outcomes & Alliance stakeholders) ion the development of long-term strategic publication plans; plans that are comprehensive and reflecting a franchise and enterprise view      

  • Ensure approval and endorsement of an integrated Early Asset publication plan by governance bodies (HQ Medical, EADT) prior to execution; continuously evolves plan in conjunction with clinical, regulatory, and scientific landscapes

  • Demonstrate understanding of the disease areas, medical strategies and objectives necessary to provide strategic input to a broad range of stakeholders on matters related to publication & scientific content planning & data dissemination/disclosure

  • Implement effective & consistent strategies for engaging external expertise (e.g. Publication Steering Committee) to advise on & shape publication plan strategy

  • Foster collaborative relationships with academic & clinical experts, publishers, medical associations & other relevant stakeholder groups

  • Review publication drafts for scientific quality and to ensure alignment & consistency with author direction, scientific communication platform & key communication points supported by data

  • Manage the author (external/internal) interface to ensure timely execution & delivery of publications in accordance with GPP3 & BMS processes

  • Employ innovative strategies and solutions in publication delivery extending the scientific reach of evidence

  • Serve as the subject matter expert on publication-related matters involving the oncology pipeline and publication point of contact for key stakeholders

  • Engage with key internal stakeholders to facilitate early identification of anticipated data disclosures that may be relevant enabling timely preparation of other data dependent communications

  • Ensure compliance with internal and external standards and models good publication practices and principles among authors and internal publication stakeholder community ensuring all publications are being authored, written, and reviewed according to GPP3 and BMS processes

  • Facilitate decision making during publication planning & execution process through effective alignment across a broad range of internal stakeholders

  • Partner with Operations & Execution Leads to assess, plan, manage and allocate resources (budget, 3rd-party Medical communication providers, biostatistical services) to ensure timely delivery of quality communications

Qualification:

Qualifications\:

  • Advanced degree\: PharmD, PhD or MD in a science subject or biomedical degree preferred; MS in biomedical discipline or equivalent with in-depth experience in publication management considered.

  • A minimum of 7 years experience within the pharmaceutical or related healthcare industry, in both a regional and global capacity.

  • Expertise across all aspects of scientific publication strategy, planning and execution during all phases of drug development and commercialization process (investigational, registrational, pre & post-launch and marketed).

  • Certification as a Medical Publication Professional (CMPP) highly desirable.

  • Scientific expertise in Oncology with a particular emphasis in early phase clinical trials and preclinical.

  • Demonstrated track record of leading and executing in highly matrix environments across a broad range of functional areas and collaborating with the Medical Affairs, Health Outcomes, R&D, regulatory, legal and commercial teams.

  • Understanding of the clinical trial design and execution, statistical methods and clinical trial data reporting requirements.

  • Understanding of good publication practices and guidance (GPP3, ICMJE), Sunshine Act, Pharma Code of Conduct, data transparency requirements and other guidance related to post-marketing practices and scientific data communication.

  • Outstanding interpersonal, written and verbal communication skills with exceptional time management skills are required for this highly visible global position.

  • Demonstrated track record of successfully managing multiple, conflicting priorities in a rapidly evolving, fast paced, highly complex environment with success outcomes

  • Working knowledge of Microsoft Suite applications and familiarity with publication management tools & systems (Datavision).

  • Ability to travel domestically and internationally approximately 25-30% of time.